The driving factors of the European NGS services market are faster and cost-efficient sequencing, rising preference of NGS over other platforms, and rising prevalence of inherited diseases. In addition, application of genomics in drug discovery, growing prevalence of cancer & other malignant diseases, and partnerships among companies, R&D centers, and universities supplement growth. However, the factors hindering the growth of the market are reliability on grants and funding from the government and decrease in capital expenditure from academic institutions. Technological advancements opened new opportunities in the market.The European NGS services market is segmented based on technology, application, end user, disease type, and country. The technology segment is classified into SBS, ion semiconductor, SBL, pyro-sequencing, and SMRT. The market is further segmented based on application into research, clinical, and sequencing applications. The sequencing application segment is further classified into RNA, targeted, exome, whole genome, chip, methyl, de novo, and others.
The European NGS services market is further segmented based on disease type into oncology (prostate, lung, & breast cancer) and rare diseases. The end user segment is further classified into research centers, academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. The market is divided based on countries into U.K., Germany, France, Italy, Spain, Netherlands, Rest of the Europe (RoE).The key market player profiled in the report are Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina INC., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science. They have implemented strategies, such as merger & acquisitions, partnerships, agreements, and others to gain strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
The report offers an in-depth analysis of current and future market trend of the European NGS services market.
An in-depth analysis of dominant market shares for each segment helps in understanding the current market trend.
The report provides a detailed analysis of key driving and restraining factors of the European NGS services market.
This report offers an extensive quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
The key manufacturers within the European NGS services market market are profiled in the report.
Geographically, the European NGS services market market is segmented into into U.K., Germany, France, Italy, Spain, Netherlands, Rest of the Europe (RoE).
The comprehensive SWOT analysis highlights the internal environment of the key manufacturers for effective strategy formulation.
KEY MARKET SEGMENTS:
By Technology
SBS
Ion Semiconductor
SBL
Pyro-Sequencing
SMRT
By Application
Research applications
Clinical applications
Sequencing
RNA-sequencing
Targeted sequencing
Exome sequencing
Whole genome sequencing
Chip-sequencing
Methyl-sequencing
De novo sequencing
Others
By Disease Type
Oncology
Lung cancer
Breast cancer
Prostate cancer
Colorectal cancer
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...